Aroa Biosurgery Balance Sheet Health
Financial Health criteria checks 5/6
Aroa Biosurgery has a total shareholder equity of NZ$94.9M and total debt of NZ$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are NZ$111.1M and NZ$16.1M respectively.
Key information
0%
Debt to equity ratio
NZ$0
Debt
Interest coverage ratio | n/a |
Cash | NZ$30.23m |
Equity | NZ$94.94m |
Total liabilities | NZ$16.12m |
Total assets | NZ$111.06m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: ARX's short term assets (NZ$69.0M) exceed its short term liabilities (NZ$9.5M).
Long Term Liabilities: ARX's short term assets (NZ$69.0M) exceed its long term liabilities (NZ$6.6M).
Debt to Equity History and Analysis
Debt Level: ARX is debt free.
Reducing Debt: ARX has no debt compared to 5 years ago when its debt to equity ratio was 202.5%.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: ARX has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if ARX has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.